Combined with the contrast-enhanced thoracoabdominal CT (Figure 1), the patient was ultimately diagnosed with lung adenocarcinoma (stage IVB, T4N3M1c) with ALK rearrangement and multiple gene mutations on February 23, 2021. Here, ALK is linked to lung adenocarcinoma.